Format
Sort by
Items per page

Send to

Choose Destination

Best matches for MED ONCOL[ta]:

Immunotherapy in triple-negative breast cancer. Katz H et al. Med Oncol. (2017)

Kefir: a powerful probiotics with anticancer properties. Sharifi M et al. Med Oncol. (2017)

KRAS, NRAS and BRAF mutations in colorectal cancer and melanoma. Cicenas J et al. Med Oncol. (2017)

Search results

Items: 1 to 20 of 3799

1.

Radiotherapy with the anti-programmed cell death ligand-1 immune checkpoint blocker avelumab: acute toxicities in triple-negative breast cancer.

Rocca E, Dispinzieri M, Lozza L, Mariani G, Di Cosimo S, Gennaro M, Valdagni R, De Santis MC.

Med Oncol. 2018 Nov 15;36(1):4. doi: 10.1007/s12032-018-1228-y.

PMID:
30443687
2.

Plasma levels of interleukin-33 and soluble suppression of tumorigenicity 2 in patients with advanced pancreatic ductal adenocarcinoma undergoing systemic chemotherapy.

Kieler M, Unseld M, Wojta J, Kaider A, Bianconi D, Demyanets S, Prager GW.

Med Oncol. 2018 Nov 13;36(1):1. doi: 10.1007/s12032-018-1223-3.

PMID:
30426271
3.

Multidisciplinary team in head and neck cancer: a management model.

De Felice F, Tombolini V, de Vincentiis M, Magliulo G, Greco A, Valentini V, Polimeni A.

Med Oncol. 2018 Nov 13;36(1):2. doi: 10.1007/s12032-018-1227-z. Review.

PMID:
30426243
4.

Unraveling KDM4 histone demethylase expression and its association with adverse cytogenetic findings in chronic lymphocytic leukemia.

Filiú-Braga LDC, Serejo TRT, Lucena-Araujo AR, Neves FAR, de Carvalho JL, Rego EM, Saldanha-Araujo F.

Med Oncol. 2018 Nov 13;36(1):3. doi: 10.1007/s12032-018-1226-0.

PMID:
30426231
5.

Evaluation of the impact of treatment with hematopoietic stem cells transplantation (HSCT) on biochemical markers of heart function and novel electrocardiographic markers of repolarization in patients with hematological malignancies.

Poręba M, Gać P, Usnarska-Zubkiewicz L, Pilecki W, Kuliczkowski K, Mazur G, Gonerska M, Sobieszczańska M, Poręba R.

Med Oncol. 2018 Oct 31;35(12):162. doi: 10.1007/s12032-018-1221-5.

6.

Effects of extracellular acidity on resistance to chemotherapy treatment: a systematic review.

da Silva VP, Mesquita CB, Nunes JS, de Bem Prunes B, Rados PV, Visioli F.

Med Oncol. 2018 Oct 30;35(12):161. doi: 10.1007/s12032-018-1214-4. Review.

PMID:
30377828
7.

Autotaxin is a novel molecular identifier of type I endometrial cancer.

Mazzocca A, Schönauer LM, De Nola R, Lippolis A, Marrano T, Loverro M, Sabbà C, Di Naro E.

Med Oncol. 2018 Oct 29;35(12):157. doi: 10.1007/s12032-018-1222-4.

PMID:
30374843
8.

The Influence of Tumor Microenvironment on ATG4D Gene Expression in Colorectal Cancer Patients.

Gil J, Ramsey D, Pawlowski P, Szmida E, Leszczynski P, Bebenek M, Sasiadek MM.

Med Oncol. 2018 Oct 29;35(12):159. doi: 10.1007/s12032-018-1220-6.

9.

Duration of adjuvant immunotherapy-biologic, clinical and economic considerations.

Stav I, Gyawali B, Goldstein DA.

Med Oncol. 2018 Oct 29;35(12):160. doi: 10.1007/s12032-018-1218-0.

PMID:
30374666
11.

Contemporary treatment of metastatic renal cell carcinoma.

Wiechno P, Kucharz J, Sadowska M, Michalski W, Sikora-Kupis B, Jonska-Gmyrek J, Poniatowska G, Nietupski K, Ossolinski K, Demkow T.

Med Oncol. 2018 Oct 27;35(12):156. doi: 10.1007/s12032-018-1217-1. Review.

PMID:
30368624
12.

Testicular teratomas: a growing problem?

Michalski W, Jonska-Gmyrek J, Poniatowska G, Kucharz J, Stelmasiak P, Nietupski K, Sadowska M, Demkow T, Wiechno P.

Med Oncol. 2018 Oct 26;35(12):153. doi: 10.1007/s12032-018-1215-3. Review.

PMID:
30367327
13.

Factors affecting crizotinib-induced hepatotoxicity in non-small cell lung cancer patients.

Jung D, Han JM, Yee J, Kim JY, Gwak HS.

Med Oncol. 2018 Oct 26;35(12):154. doi: 10.1007/s12032-018-1213-5.

PMID:
30367285
14.

Letter to the editor regarding "Ultrasound features of breast cancer for predicting axillary lymph node metastasis".

Zeng Z.

Med Oncol. 2018 Oct 26;35(12):155. doi: 10.1007/s12032-018-1216-2. No abstract available.

PMID:
30367277
15.

Association of ERG/PTEN status with biochemical recurrence after radical prostatectomy for clinically localized prostate cancer.

Mehra R, Salami SS, Lonigro R, Bhalla R, Siddiqui J, Cao X, Spratt DE, Palapattu GS, Palanisamy N, Wei JT, Chinnaiyan AM, Tomlins SA.

Med Oncol. 2018 Oct 5;35(12):152. doi: 10.1007/s12032-018-1212-6.

PMID:
30291535
16.

The use of radiofrequency ablation in pancreatic cancer in the midst of the dawn of immuno-oncology.

Reccia I, Kumar J, Habib N, Sodergren M.

Med Oncol. 2018 Oct 4;35(12):151. doi: 10.1007/s12032-018-1209-1.

PMID:
30284649
17.

Volumetric modulated arc therapy (VMAT) in the treatment of esophageal cancer patients.

Martini S, Arcadipane F, Strignano P, Spadi R, Contu V, Fiandra C, Ragona R, Catalano G, Satolli MA, Camandona M, Romagnoli R, Ricardi U, Franco P.

Med Oncol. 2018 Oct 4;35(12):150. doi: 10.1007/s12032-018-1211-7.

PMID:
30284647
18.

Droplet digital PCR using HER2/EIF2C1 ratio for detection of HER2 amplification in breast cancer tissues.

Tantiwetrueangdet A, Panvichian R, Wongwaisayawan S, Sueangoen N, Lertsithichai P.

Med Oncol. 2018 Oct 3;35(12):149. doi: 10.1007/s12032-018-1210-8.

19.

Hypofractionated stereotactic radiotherapy for oligometastatic patients: developing of a response predictive model.

Diletto B, Dinapoli N, Chiesa S, Mattiucci GC, Frascino V, Anile C, Colosimo C, Valentini V, Balducci M.

Med Oncol. 2018 Sep 14;35(11):146. doi: 10.1007/s12032-018-1206-4.

PMID:
30218407
20.

Imaging of distant metastases of prostate cancer.

Pesapane F, Czarniecki M, Suter MB, Turkbey B, Villeirs G.

Med Oncol. 2018 Sep 14;35(11):148. doi: 10.1007/s12032-018-1208-2. Review.

PMID:
30218382

Supplemental Content

Loading ...
Support Center